Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups.

PubWeight™: 1.73‹?› | Rank: Top 3%

🔗 View Article (PMID 7541833)

Published in J Pediatr on July 01, 1995

Authors

A B Moser1, M Rasmussen, S Naidu, P A Watkins, M McGuinness, A K Hajra, G Chen, G Raymond, A Liu, D Gordon

Author Affiliations

1: Kennedy Krieger Institute, Baltimore, MD 21205, USA.

Articles citing this

Prioritizing candidate disease genes by network-based boosting of genome-wide association data. Genome Res (2011) 4.39

Multiple PEX genes are required for proper subcellular distribution and stability of Pex5p, the PTS1 receptor: evidence that PTS1 protein import is mediated by a cycling receptor. J Cell Biol (1996) 2.03

Peroxisome synthesis in the absence of preexisting peroxisomes. J Cell Biol (1999) 1.80

The peroxisome biogenesis disorder group 4 gene, PXAAA1, encodes a cytoplasmic ATPase required for stability of the PTS1 receptor. EMBO J (1996) 1.62

Mutation in PEX16 is causal in the peroxisome-deficient Zellweger syndrome of complementation group D. Am J Hum Genet (1998) 1.35

Targeting of human catalase to peroxisomes is dependent upon a novel COOH-terminal peroxisomal targeting sequence. J Cell Biol (1996) 1.33

Plasmalogens as endogenous antioxidants: somatic cell mutants reveal the importance of the vinyl ether. Biochem J (1999) 1.31

Identification of PEX10, the gene defective in complementation group 7 of the peroxisome-biogenesis disorders. Am J Hum Genet (1998) 1.31

PEX11 beta deficiency is lethal and impairs neuronal migration but does not abrogate peroxisome function. Mol Cell Biol (2002) 1.28

Disruption of a PEX1-PEX6 interaction is the most common cause of the neurologic disorders Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease. Proc Natl Acad Sci U S A (1998) 1.22

A syndrome of severe mental retardation, spasticity, and tapetoretinal degeneration linked to chromosome 15q24. Am J Hum Genet (1998) 1.15

Identification and characterization of the human orthologue of yeast Pex14p. Mol Cell Biol (1999) 1.12

Human PEX1 cloned by functional complementation on a CHO cell mutant is responsible for peroxisome-deficient Zellweger syndrome of complementation group I. Proc Natl Acad Sci U S A (1998) 1.11

Peroxisomal D-hydroxyacyl-CoA dehydrogenase deficiency: resolution of the enzyme defect and its molecular basis in bifunctional protein deficiency. Proc Natl Acad Sci U S A (1998) 1.09

Peroxisomal bifunctional protein deficiency revisited: resolution of its true enzymatic and molecular basis. Am J Hum Genet (1999) 1.08

A PEX6-defective peroxisomal biogenesis disorder with severe phenotype in an infant, versus mild phenotype resembling Usher syndrome in the affected parents. Am J Hum Genet (2002) 1.07

The peroxin pex3p initiates membrane assembly in peroxisome biogenesis. Mol Biol Cell (2000) 1.05

PEX12, the pathogenic gene of group III Zellweger syndrome: cDNA cloning by functional complementation on a CHO cell mutant, patient analysis, and characterization of PEX12p. Mol Cell Biol (1998) 1.05

Targeted deletion of the PEX2 peroxisome assembly gene in mice provides a model for Zellweger syndrome, a human neuronal migration disorder. J Cell Biol (1997) 1.02

Isolation of a Chinese hamster fibroblast variant defective in dihydroxyacetonephosphate acyltransferase activity and plasmalogen biosynthesis: use of a novel two-step selection protocol. Biochem J (1998) 1.00

Rational diagnostic strategy for Zellweger syndrome spectrum patients. Eur J Hum Genet (2009) 1.00

Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1) and DXS1357E: a novel neonatal phenotype similar to peroxisomal biogenesis disorders. Am J Hum Genet (2002) 1.00

Identification of novel mutations and sequence variation in the Zellweger syndrome spectrum of peroxisome biogenesis disorders. Hum Mutat (2009) 0.99

Disorders of peroxisome biogenesis due to mutations in PEX1: phenotypes and PEX1 protein levels. Am J Hum Genet (2001) 0.94

Leukoencephalopathies associated with inborn errors of metabolism in adults. J Inherit Metab Dis (2008) 0.92

Mutations in novel peroxin gene PEX26 that cause peroxisome-biogenesis disorders of complementation group 8 provide a genotype-phenotype correlation. Am J Hum Genet (2003) 0.91

Phenotype-genotype relationships in complementation group 3 of the peroxisome-biogenesis disorders. Am J Hum Genet (1998) 0.90

A PEX10 defect in a patient with no detectable defect in peroxisome assembly or metabolism in cultured fibroblasts. J Inherit Metab Dis (2008) 0.90

Zellweger spectrum disorders: clinical overview and management approach. Orphanet J Rare Dis (2015) 0.87

Biology of senescent liver peroxisomes: role in hepatocellular aging and disease. Environ Health Perspect (1999) 0.87

Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood. J Inherit Metab Dis (2015) 0.83

A Drosophila model for the Zellweger spectrum of peroxisome biogenesis disorders. Dis Model Mech (2011) 0.83

Disorders of peroxisome biogenesis: complementation analysis shows genetic heterogeneity with strong overrepresentation of one group (PEX1 deficiency). J Inherit Metab Dis (1999) 0.81

Disorders related to peroxisomal membranes. J Inherit Metab Dis (2000) 0.78

Biochemical analysis of cultured chorionic villi for the prenatal diagnosis of peroxisomal disorders: biochemical thresholds and molecular sensitivity for maternal cell contamination detection. J Med Genet (2005) 0.78

Absence of mutations raises doubts about the role of the 70-kD peroxisomal membrane protein in Zellweger syndrome. Am J Hum Genet (1997) 0.77

A new peroxisomal beta-oxidation disorder in twin neonates: defective oxidation of both cerotic and pristanic acids. J Inherit Metab Dis (1997) 0.75

Clinical utility gene card for: Zellweger syndrome spectrum. Eur J Hum Genet (2014) 0.75

Complementation analysis in patients with the clinical phenotype of a generalised peroxisomal disorder. J Med Genet (1996) 0.75

Diagnostic work-up of a peroxisomal patient. J Inherit Metab Dis (1995) 0.75

Identification of a novel mutation in PEX10 in a patient with attenuated Zellweger spectrum disorder: a case report. J Med Case Rep (2017) 0.75

Articles by these authors

(truncated to the top 100)

Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature (2001) 11.72

Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science (1981) 10.62

The genome of the social amoeba Dictyostelium discoideum. Nature (2005) 9.18

Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans Med Imaging (2001) 8.14

The genome of the natural genetic engineer Agrobacterium tumefaciens C58. Science (2001) 6.90

Radical SAM, a novel protein superfamily linking unresolved steps in familiar biosynthetic pathways with radical mechanisms: functional characterization using new analysis and information visualization methods. Nucleic Acids Res (2001) 6.49

TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. Biochem Biophys Res Commun (1999) 6.33

Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes (2000) 6.27

Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol (1985) 5.67

NMR solution structure of the human prion protein. Proc Natl Acad Sci U S A (2000) 4.80

A genetic map and recombination parameters of the human malaria parasite Plasmodium falciparum. Science (1999) 4.75

Diversity and depth-specific distribution of SAR11 cluster rRNA genes from marine planktonic bacteria. Appl Environ Microbiol (1997) 4.71

Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science (2000) 4.57

BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo. Cancer Res (1999) 4.16

Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription. Mol Cell (1998) 4.03

The primary sequence of rabbit alpha-globin mRNA. Cell (1978) 3.88

Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest (1991) 3.82

Predictive testing for Huntington's disease with use of a linked DNA marker. N Engl J Med (1988) 3.82

Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest (1988) 3.76

A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE investigators. N Engl J Med (1993) 3.75

Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am J Pathol (1994) 3.57

Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial. Cancer J (2001) 3.56

The causal links between stress and burnout in a longitudinal study of UK doctors. Lancet (2002) 3.45

Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A (1989) 3.37

Control of lymphokine secretion by prostaglandins. Nature (1976) 3.34

Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J (1996) 3.18

Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome. Mol Cell (1998) 3.09

Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci U S A (1997) 3.07

Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Nat Genet (2001) 3.05

Expression of smooth muscle-specific alpha-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation. J Cell Biol (1986) 3.00

T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci U S A (1992) 2.98

The Health Behaviour in School-aged Children (HBSC) study: methodological developments and current tensions. Int J Public Health (2009) 2.93

A deprivation index for health and welfare planning in Quebec. Chronic Dis Can (2000) 2.93

HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization. Am J Pathol (1987) 2.91

Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science (1994) 2.79

Hemodynamic regulation: investigation by spectral analysis. Am J Physiol (1985) 2.79

Effects of subanaesthetic and anaesthetic doses of sevoflurane on regional cerebral blood flow in healthy volunteers. A positron emission tomographic study. Acta Anaesthesiol Scand (2004) 2.74

Coordination of a transcriptional switch by HMGI(Y) acetylation. Science (2001) 2.69

BNIP3 heterodimerizes with Bcl-2/Bcl-X(L) and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites. J Biol Chem (2000) 2.68

Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med (1993) 2.62

Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet (1997) 2.53

Indian Agarwal megalencephalic leukodystrophy with cysts is caused by a common MLC1 mutation. Neurology (2004) 2.48

Medtronic Intact porcine bioprosthesis: clinical performance to seven years. Ann Thorac Surg (1995) 2.48

Alexander disease: diagnosis with MR imaging. AJNR Am J Neuroradiol (2001) 2.43

Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet (1999) 2.42

MR findings in adult-onset adrenoleukodystrophy. AJNR Am J Neuroradiol (1995) 2.42

A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes. J Cell Biol (1985) 2.38

Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther (2007) 2.38

Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci U S A (1993) 2.35

Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia. Clin Cancer Res (2001) 2.35

Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development (1992) 2.34

A deprivation index for health planning in Canada. Chronic Dis Can (2009) 2.33

Lithium-induced increase in human brain grey matter. Lancet (2000) 2.31

An efficient algorithm for spectral analysis of heart rate variability. IEEE Trans Biomed Eng (1986) 2.31

Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. Radiology (1999) 2.24

Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol (2003) 2.23

Substituted 2,5'-Bi-1H-benzimidazoles: topoisomerase I inhibition and cytotoxicity. J Med Chem (1996) 2.20

On extraction of acyl and alkyl dihydroxyacetone phosphate from incubation mixtures. Lipids (1974) 2.16

Examination of acetaminophen for outpatient management of postoperative pain in children. Paediatr Anaesth (1998) 2.15

Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol (2004) 2.14

Lysosomal glycogen storage disease with normal acid maltase. Neurology (1981) 2.13

Feeding and nutritional characteristics in children with moderate or severe cerebral palsy. Acta Paediatr (1996) 2.09

Raman scattering from high-frequency phonons in supported n-graphene layer films. Nano Lett (2006) 2.08

Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy. Nat Med (1998) 2.08

Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls. Ann Neurol (1999) 2.06

Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci U S A (1993) 2.03

DNA from soil mirrors plant taxonomic and growth form diversity. Mol Ecol (2012) 2.03

MR imaging differentiation of benign and malignant peripheral nerve sheath tumors: use of the target sign. Pediatr Radiol (1997) 2.02

Conversion of dorsal from an activator to a repressor by the global corepressor Groucho. Genes Dev (1997) 1.99

Guidelines for reporting clinical features in cases with MECP2 mutations. Brain Dev (2001) 1.99

Rett syndrome: confirmation of X-linked dominant inheritance, and localization of the gene to Xq28. Am J Hum Genet (1998) 1.98

Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy (2008) 1.97

Expression of an Arabidopsis cryptochrome gene in transgenic tobacco results in hypersensitivity to blue, UV-A, and green light. Proc Natl Acad Sci U S A (1995) 1.96

Radiology report production times: voice recognition vs. transcription. Radiol Manage (2001) 1.95

Thermal conductivity spectroscopy technique to measure phonon mean free paths. Phys Rev Lett (2011) 1.94

Local and propagated vascular responses evoked by focal synaptic activity in cerebellar cortex. J Neurophysiol (1997) 1.93

Trigeminocardiac reflex in embolization of intracranial dural arteriovenous fistula. AJNR Am J Neuroradiol (2007) 1.91

Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet (2001) 1.91

Chemokine-dependent neutrophil recruitment in a murine model of Legionella pneumonia: potential role of neutrophils as immunoregulatory cells. Infect Immun (2001) 1.88

Protein folding is slaved to solvent motions. Proc Natl Acad Sci U S A (2006) 1.88

Effect of NASA light-emitting diode irradiation on wound healing. J Clin Laser Med Surg (2001) 1.85

Children of depressed mothers: maternal strain and symptom predictors of dysfunction. J Abnorm Psychol (1987) 1.83

Glycerolipid biosynthesis in peroxisomes via the acyl dihydroxyacetone phosphate pathway. Ann N Y Acad Sci (1982) 1.83

Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes Relat Metab Disord (1995) 1.83

Investigating neural primacy in Major Depressive Disorder: multivariate Granger causality analysis of resting-state fMRI time-series data. Mol Psychiatry (2010) 1.83

Recommendations for the control of Yersinia pestis infections. Recommendations from the CDC. Infect Control (1981) 1.81

Numerical selection of optimal tumor imaging agents with application to engineered antibodies. Cancer Biother Radiopharm (2001) 1.81

Association of phosphatidylinositol 3-kinase with nuclear transcription sites in higher plants. Plant Cell (2000) 1.81

Quantitative analysis of the effect of the mutation frequency on the affinity maturation of single chain Fv antibodies. Proc Natl Acad Sci U S A (2000) 1.80

Lumbar hernia: clinical analysis of 11 cases. Hernia (2004) 1.79

BICAV: a block-iterative parallel algorithm for sparse systems with pixel-related weighting. IEEE Trans Med Imaging (2001) 1.79

Role of matrix metalloproteinases in renal pathophysiologies. Am J Physiol Renal Physiol (2006) 1.79

A method for the chemical synthesis of 14C-labeled fatty acyl coenzyme A's of high specific activity. Anal Biochem (1980) 1.78

Genetic switching in the flagellar gene hierarchy of Caulobacter requires negative as well as positive regulation of transcription. Proc Natl Acad Sci U S A (1989) 1.78

Identification and characterization of a new mammalian glutaredoxin (thioltransferase), Grx2. J Biol Chem (2001) 1.77

Regional studies in skin cancer. 2. Wet tropical and subtropical coasts of Queensland. Med J Aust (1966) 1.75

Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein. Cancer Chemother Pharmacol (1997) 1.73

The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. J Biol Chem (2001) 1.73

Studies of intestinal lymphoid tissue. IX. Dose-dependent, gluten-induced lymphoid infiltration of coeliac jejunal epithelium. Scand J Gastroenterol (1985) 1.73

Control of protein-ligand recognition using a stimuli-responsive polymer. Nature (1995) 1.73